Clinical Trials Logo
  1. Home
  2. Other
  3. NCT02034604

Efficacy and Safety of Naftopidil in Patient With Neurogenic Lower Urinary Tract Dysfunction Not Caused by Benign Prostatic Hyperplasia

Neurogenic Lower Urinary Tract Dysfunction Clinical Trial

Clinical Trial Summary

This study is designed to evaluate efficacy and safety of naftopidil in patient with neurogenic lower urinary tract dysfunction not caused by benign prostatic hyperplasia.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

  • Neurogenic Lower Urinary Tract Dysfunction
Clinical Trial Details
NCT number NCT02034604
Study type Interventional
Source Samsung Medical Center
Contact
Status Completed
Phase Phase 4
Start date December 2013
Completion date August 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT02138149 - Is the Nerve Growth Factor (NGF) a Useful Biomarker in Neurogenic Bladder Dysfunction After Spinal Cord Injury? N/A
Completed NCT02443870 - Long-term Urodynamics in Individuals With Neurogenic Lower Urinary Tract Dysfunction
Suspended NCT02449512 - Somatosensory Evoked Potentials From the Lower Urinary Tract
Completed NCT02138201 - Representation of the Bladder Innervation Using Diffusion Tensor Imaging Fiber Tracking With MRI - a Pilot Study N/A
Completed NCT01768910 - Supraspinal Control of Lower Urinary Tract Function in Healthy Controls and Patients With Bladder Dysfunction N/A
Completed NCT05003999 - Time Needed to Perform Intermittent Catheterization in Adults With Spinal Cord Injuries N/A